Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ)

Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) — VMCI valuation read

002317.SZ screens at VMCI 43/100, a 7-point gap below the Healthcare sector median (50). For a mid-cap Guangdong Zhongsheng Pharmaceutical Co., Ltd. share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

002317.SZ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 002317.SZ trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 0.2x leaves covenant headroom, which sets the rate-cycle exposure for Guangdong Zhongsheng Pharmaceutical Co., Ltd..

002317.SZ fell 2.0% over the trailing 7 days, with a -18.8% read on a 30-day basis.